Eblasakimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Eblasakimab, covering 2024-01-18 to 2024-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab [Phase 2]